Yüklüyor......

Optimum Use of Acute Treatments for Hereditary Angioedema: Evidence-Based Expert Consensus

Acute treatment of hereditary angioedema due to C1 inhibitor deficiency has become available in the last 10 years and has greatly improved patients’ quality of life. Two plasma-derived C1 inhibitors (Berinert and Cinryze), a recombinant C1 inhibitor (Ruconest/Conestat alpha), a kallikrein inhibitor...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Front Med (Lausanne)
Yazar: Longhurst, Hilary
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Frontiers Media S.A. 2018
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5857575/
https://ncbi.nlm.nih.gov/pubmed/29594115
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmed.2017.00245
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!